OPGEN INC Uncategorized Contracts & Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated April 23, 2024, between OpGen, Inc. and Camtech Pte Ltd
OPGEN INC
Biotechnology
2024
Form of Inducement Offer to Amend Common Stock Purchase Warrants, dated March 26, 2024
OPGEN INC
Biotechnology
2024
Form of Director Agreement
OPGEN INC
Biotechnology
DE
2024
Agreement, dated March 25, 2024, by and between Insolvency Administrator for Curetis GmbH and the Company
OPGEN INC
Biotechnology
2024
Settlement Agreement, dated March 25, 2024, by and between the European Investment Bank and the Company
OPGEN INC
Biotechnology
2024
Form of Securities Purchase Agreement, dated as of March 25, 2024, by and between the Company and David Lazar
OPGEN INC
Biotechnology
NV
2024
Form of Securities Purchased Agreement, dated October 11, 2023, by and between the Company and the Investor
OPGEN INC
Biotechnology
DE
2023
Standstill Agreement, dated July 4, 2023, by and between OpGen, Inc. and the Investor
OPGEN INC
Biotechnology
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPGEN INC
Biotechnology
2023
At the Market Offering Agreement, dated June 24, 2022, by and between OpGen, Inc. and H.C. Wainwright & Co., LLC
OPGEN INC
Biotechnology
NY
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPGEN INC
Biotechnology
2022
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPGEN INC
Biotechnology
2021
Letter Agreement, dated as of March 9, 2021, by and between A.G.P./Alliance Global Partners and OpGen, Inc
OPGEN INC
Biotechnology
2021
Placement Agent Agreement, dated February 9, 2021, by and between OpGen, Inc. and A.G.P./Alliance Global Partners
OPGEN INC
Biotechnology
NY
2021
Placement Agent Agreement, dated November 23, 2020, by and between OpGen, Inc. and Alliance Global Partners
OPGEN INC
Biotechnology
NY
2020
Amended and Restated At the Market Offering Agreement, dated November 13, 2020, by and among OpGen, Inc., H.C. Wainwright & Co., LLC and BTIG, LLC
OPGEN INC
Biotechnology
NY
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPGEN INC
Biotechnology
2020
At the Market Offering Agreement, by and between OpGen, Inc. and H.C. Wainwright & Co., LLC dated February 11, 20202
OPGEN INC
Biotechnology
NY
2020
Implementation Agreement, dated as of September 4, 2019, by and among Curetis N.V., as Seller, and Crystal GmbH, as Purchaser and OpGen, Inc
OPGEN INC
Biotechnology
DE
2019
Engagement Letter, dated as of December 18, 2017, between the Registrant and H.C. Wainwright & Co., LLC
OPGEN INC
Biotechnology
NY
2018
Engagement Letter, dated June 12, 2017, between the Registrant and H.C. Wainwright & Co., LLC
OPGEN INC
Biotechnology
NY
2017
CUMMINGS PROPERTIES, LLC STANDARD FORM COMMERCIAL LEASE03030131-AFA
OPGEN INC
Biotechnology
MA
2016
EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECTOF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIESAND...
OPGEN INC
Biotechnology
CA
2015
AMENDED AND RESTATED INTERCREDITOR AGREEMENT
OPGEN INC
Biotechnology
2015
EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND...
OPGEN INC
Biotechnology
CA
2015
Attachment A Proprietary Information Agreement Attachment B Outside Activities
OPGEN INC
Biotechnology
MD
2015
SECOND STOCKHOLDERS' AGREEMENTS AMENDMENT
OPGEN INC
Biotechnology
2015
STOCKHOLDERS AGREEMENTS AMENDMENT
OPGEN INC
Biotechnology
2015